Amikacin inj (500mg)

•  Musculoskeletal: Muscle weakness (due to blocking of signals from the nerves to the muscles).

•  Eye and ENT: Hearing loss and loss of balance.

•  Genitourinary: Reduced urine volume, protein in urine, increased serum creatinine, urinary casts, red and white blood cells in urine and high level of nitrogen waste in blood (azotemia).

•  Miscellaneous: Decreased serum magnesium.

The recommended dose is 15mg/kg/day in 1-3 doses, urinary tract infection 250mg twice a day.

This medication available in the form of injection, administered by a healthcare professional.

Generally not indicated for long-term therapy because of ototoxicity (damage to the ear) and nephrotoxicity (damage to kidney cells).

• Caution should be exercised in patients with history of kidney disease, vertigo, hearing loss, ringing in the ears, myasthenia gravis, or Parkinson's disease, during pregnancy.

• Discontinue, if signs of ototoxicity, neurotoxicity or hypersensitivity occurs; and during lactation.

• Safety has not been established for treatment period >14 days.

• Monitor renal function before and during treatment.

Do not change the dose without consulting your doctor.

Injection: Store it in the refrigerator or freezer. Take your next dose from the refrigerator 1 hour before using it; place it in a clean, dry area to allow it to warm to room temperature. Do not refreeze medications.

Schedule : H  Prescription drugs - Drugs to be sold only under the prescription of a Registered Medical Practitioner.